Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

WT1 (Wilms' tumor suppressor gene)

Identity

HGNC WT1
Location 11p13
Location_base_pair Starts at 32365901 and ends at 32413663 bp from pter ( according to hg18-Mar_2006).
Local_order Cen-RAG1/2-CAT-CD59-WT1-RCN-PAX6-FSHB-tel

DNA/RNA

Description 10 exons spanning 48 kb of genomic DNA
Transcription 3 kb mRNA; four alternative splice forms: +/- exon 5 and alternative splice donor sites at exon 9

Protein

Description four major isoforms (429-449 aa) due to alternative splicing; there are eight minor isoforms resulting from different initiation sites (upstream CTG: 502-522 aa, downstream ATG: 303-323 aa)
Expression kidney, spleen, mesothelia
Localisation nuclear staining, either diffuse or in speckles, depending on isoform and mutations
Function zinc finger transcription factor (4 C2H2-type fingers)
Homology Sp1, Egr-1

Mutations

Germinal various types of mutations, mostly affecting zinc fingers in exons 7-10. (WAGR syndrome, genito-urinary (GU) anomalies, Denys-Drash-syndrome, Frasier syndrome; see below)
Somatic biallelic inactivation in Wilms' tumors (<15%) and some mesotheliomas and granulosa cell tumors

Implicated in

Entity Wilms' tumor
Disease nephroblastoma of childhood
Prognosis good with treatment according to NWTS or SIOP
Cytogenetics 11p13 deletions/translocations can be seen in some cases
Oncogenesis up to 15% of tumors show mainly biallelic inactivation of WT1 through deletion or mutatio
  
Entity desmoplastic small round cell tumor (DSRCT)
Prognosis poor
Cytogenetics translocations, t(11;22)(p13;q12)
Abnormal Protein With EWS: EWS-WT; in frame fusion of EWS exons 1-7 and WT1 exons 8-10
  
Entity Denys-Drash syndrome (DDS)
Disease defined by: mesangial sclerosis with kidney failure (age 2 yrs), gonadal dysgenesis, risk of Wilms' tumors
Prognosis kidney failure at age 0-5 years
Hybrid/Mutated Gene dominant negative mutations, especially missense mutations within the zinc fingers (aa 394 Arg -> Trp) but very few nonsense mutations
Oncogenesis high risk of Wilms' tumor development
  
Entity Frasier syndrome
Disease defined by: complete gonadal dysgenesis, focal glomerular sclerosis, gonadoblastoma; in karyotypic females the syndrome may be limited to focal glomerular sclerosis with regular gonadal development and function
Prognosis kidney failure at age 10-30 years
Hybrid/Mutated Gene heterozygous point mutations of alternative splice donor site in exon 9 with imbalance of WT1 isoform ratio
Oncogenesis gonadoblatoma may occur within streak gonads
  

External links

Nomenclature
HGNCWT1   12796
Entrez_GeneWT1  7490  Wilms tumor 1
Cards
AtlasWT1ID78
GeneCardsWT1
EnsemblENSG00000184937 [Gene_View]  WT1 [Vega]
GenatlasWT1
Genomic and cartography
GoldenPathWT1  -  11p13   chr11:32365901-32413663 -  11p13   [Description]    (hg18-Mar_2006)
EnsemblWT1 - 11p13 [CytoView]
NCBIMapview
OMIM136680 Disease map [OMIM]
OMIM194070 Disease map [OMIM]
OMIM194072 Disease map [OMIM]
OMIM194080 Disease map [OMIM]
OMIM256370 Disease map [OMIM]
OMIM607102 Disease map [OMIM]
HomoloGeneWT1
Gene and transcription
GenbankAK093168 [ ENTREZ ]
GenbankAK291736 [ ENTREZ ]
GenbankBC032861 [ ENTREZ ]
GenbankBC046461 [ ENTREZ ]
GenbankM30393 [ ENTREZ ]
RefSeqNM_000378 [ SRS ]    NM_000378 [ ENTREZ ]
RefSeqNM_024424 [ SRS ]    NM_024424 [ ENTREZ ]
RefSeqNM_024425 [ SRS ]    NM_024425 [ ENTREZ ]
RefSeqNM_024426 [ SRS ]    NM_024426 [ ENTREZ ]
RefSeqAC_000054 [ SRS ]    AC_000054 [ ENTREZ ]
RefSeqAC_000143 [ SRS ]    AC_000143 [ ENTREZ ]
RefSeqNC_000011 [ SRS ]    NC_000011 [ ENTREZ ]
RefSeqNT_009237 [ SRS ]    NT_009237 [ ENTREZ ]
RefSeqNW_001838022 [ SRS ]    NW_001838022 [ ENTREZ ]
RefSeqNW_925006 [ SRS ]    NW_925006 [ ENTREZ ]
CCDSWT1 CCDS - NCBI
AceViewWT1 AceView - NCBI
UnigeneHs.591980 [ SRS ]    Hs.591980 [ NCBI ]
Fast-db4548 (alternative variants)
Protein : pattern, domain, 3D structure
SwissProtP19544 [ SRS]    P19544 [ EXPASY ]     P19544 [ INTERPRO ]     P19544 [ UNIPROT ] P19544 [ VarSplice FASTA ]
PrositePS00028 ZINC_FINGER_C2H2_1 [ SRS ]    PS00028 ZINC_FINGER_C2H2_1 [ Expasy ]
PrositePS50157 ZINC_FINGER_C2H2_2 [ SRS ]    PS50157 ZINC_FINGER_C2H2_2 [ Expasy ]
InterproIPR000976 Wilms_tumour [ SRS ]    IPR000976 Wilms_tumour [ EBI ]
InterproIPR007087 Znf_C2H2 [ SRS ]    IPR007087 Znf_C2H2 [ EBI ]
InterproIPR015880 Znf_C2H2-like [ SRS ]    IPR015880 Znf_C2H2-like [ EBI ]
InterproIPR013087 Znf_C2H2/integrase_DNA-bd [ SRS ]    IPR013087 Znf_C2H2/integrase_DNA-bd [ EBI ]
CluSTrP19544
PfamPF02165 WT1 [ SRS ]    PF02165 WT1 [ Sanger ]    pfam02165 [ NCBI-CDD ]
PfamPF00096 zf-C2H2 [ SRS ]    PF00096 zf-C2H2 [ Sanger ]    pfam00096 [ NCBI-CDD ]
SmartSM00355 ZnF_C2H2 [EMBL]
ProdomPD000003 Znf_C2H2[INRA-Toulouse]
ProdomP19544 WT1_HUMAN [ Domain structure ]   P19544 WT1_HUMAN  [ sequences sharing at least 1 domain ]
BlocksP19544
PDB1LU6 [ SRS ]    1LU6 [ PdbSum ],   1LU6 [ IMB ]   1LU6 [ RSDB ]
PDB1XF7 [ SRS ]    1XF7 [ PdbSum ],   1XF7 [ IMB ]   1XF7 [ RSDB ]
PDB2G7T [ SRS ]    2G7T [ PdbSum ],   2G7T [ IMB ]   2G7T [ RSDB ]
PDB2G7V [ SRS ]    2G7V [ PdbSum ],   2G7V [ IMB ]   2G7V [ RSDB ]
PDB2G7W [ SRS ]    2G7W [ PdbSum ],   2G7W [ IMB ]   2G7W [ RSDB ]
PDB2G7X [ SRS ]    2G7X [ PdbSum ],   2G7X [ IMB ]   2G7X [ RSDB ]
HPRD06163
Protein Interaction databases
DIPP19544
IntActP19544
Polymorphism : SNP, mutations, diseases
OMIM136680    [ map ]   
OMIM194070    [ map ]   
OMIM194072    [ map ]   
OMIM194080    [ map ]   
OMIM256370    [ map ]   
OMIM607102    [ map ]   
GENETests136680
GENETests194070
GENETests194072
GENETests194080
GENETests256370
GENETests607102
SNPWT1 [dbSNP-NCBI]  
SNPNM_000378 [SNP-NCI]  
SNPNM_024424 [SNP-NCI]  
SNPNM_024425 [SNP-NCI]  
SNPNM_024426 [SNP-NCI]  
SNPWT1 [GeneSNPs - Utah]  WT1] [HGBASE - SRS]
HAPMAPWT1 [HAPMAP]  
COSMICWT1 [Somatic mutation (COSMIC-CGP-Sanger)]  
TICdbWT1 [Translocation breakpoints In Cancer]  
HGMDWT1
Genetic AssociationWT1
CDC HuGEWT1
General knowledge
Family BrowserWT1 [UCSC Family Browser]
SOURCENM_000378
SOURCENM_024424
SOURCENM_024425
SOURCENM_024426
SMDHs.591980
SAGEHs.591980
GOnegative regulation of transcription from RNA polymerase II promoter [Amigo]  negative regulation of transcription from RNA polymerase II promoter
GOtranscription factor activity [Amigo]  transcription factor activity
GOintracellular [Amigo]  intracellular
GOnucleus [Amigo]  nucleus
GOtranscription [Amigo]  transcription
GOregulation of transcription, DNA-dependent [Amigo]  regulation of transcription, DNA-dependent
GOzinc ion binding [Amigo]  zinc ion binding
GOnegative regulation of cell cycle [Amigo]  negative regulation of cell cycle
GOmetal ion binding [Amigo]  metal ion binding
BIOCARTAOverview of telomerase protein component gene hTert Transcriptional Regulation    [Genes]
BIOCARTAChaperones modulate interferon Signaling Pathway    [Genes]
PubGeneWT1
TreeFamWT1
CTD7490 [Comparative ToxicoGenomics Database]
Other databases
Other databaseWT1 mutation database
Probes
ProbeWT1 Related clones (RZPD - Berlin)
PubMed
PubMed184 Pubmed reference(s) in Entrez

Bibliography

Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus.
Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH
Cell. 1990 ; 60 (3) : 509-520.
PMID 2154335
 
Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping.
Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GA
Nature. 1990 ; 343 (6260) : 774-778.
PMID 2154702
 
Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence.
Rauscher FJ 3rd, Morris JF, Tournay OE, Cook DM, Curran T
Science (New York, N.Y.). 1990 ; 250 (4985) : 1259-1262.
PMID 2244209
 
Alternative splicing and genomic structure of the Wilms tumor gene WT1.
Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM, Housman DE
Proceedings of the National Academy of Sciences of the United States of America. 1991 ; 88 (21) : 9618-9622.
PMID 1658787
 
Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome.
Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L
Cell. 1991 ; 67 (2) : 437-447.
PMID 1655284
 
The genomic organization and expression of the WT1 gene.
Gessler M, Knig A, Bruns GA
Genomics. 1992 ; 12 (4) : 807-813.
PMID 1572653
 
The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo.
Armstrong JF, Pritchard-Jones K, Bickmore WA, Hastie ND, Bard JB
Mechanisms of development. 1993 ; 40 (1-2) : 85-97.
PMID 8382938
 
Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
Gessler M, Knig A, Arden K, Grundy P, Orkin S, Sallan S, Peters C, Ruyle S, Mandell J, Li F
Human mutation. 1994 ; 3 (3) : 212-222.
PMID 8019557
 
Fine structure analysis of the WT1 gene in sporadic Wilms tumors.
Varanasi R, Bardeesy N, Ghahremani M, Petruzzi MJ, Nowak N, Adam MA, Grundy P, Shows TB, Pelletier J
Proceedings of the National Academy of Sciences of the United States of America. 1994 ; 91 (9) : 3554-3558.
PMID 8170946
 
Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor.
Gerald WL, Rosai J, Ladanyi M
Proceedings of the National Academy of Sciences of the United States of America. 1995 ; 92 (4) : 1028-1032.
PMID 7862627
 
Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing.
Larsson SH, Charlieu JP, Miyagawa K, Engelkamp D, Rassoulzadegan M, Ross A, Cuzin F, van Heyningen V, Hastie ND
Cell. 1995 ; 81 (3) : 391-401.
PMID 7736591
 
A non-AUG translational initiation event generates novel WT1 isoforms.
Bruening W, Pelletier J
The Journal of biological chemistry. 1996 ; 271 (15) : 8646-8654.
PMID 8621495
 
A clinical overview of WT1 gene mutations.
Little M, Wells C
Human mutation. 1997 ; 9 (3) : 209-225.
PMID 9090524
 
Donor splice-site mutations in WT1 are responsible for Frasier syndrome.
Barbaux S, Niaudet P, Gubler MC, Grnfeld JP, Jaubert F, Kuttenn F, Fkt CN, Souleyreau-Therville N, Thibaud E, Fellous M, McElreavey K
Nature genetics. 1997 ; 17 (4) : 467-470.
PMID 9398852
 
Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/-KTS splice isoforms.
Klamt B, Koziell A, Poulat F, Wieacker P, Scambler P, Berta P, Gessler M
Human molecular genetics. 1998 ; 7 (4) : 709-714.
PMID 9499425
 
Internal translation initiation generates novel WT1 protein isoforms with distinct biological properties.
Scharnhorst V, Dekker P, van der Eb AJ, Jochemsen AG
The Journal of biological chemistry. 1999 ; 274 (33) : 23456-23462.
PMID 10438524
 
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Search in all EBI   NCBI

Contributor(s)

Written10-1999Manfred Gessler

Citation

This paper should be referenced as such :
Gessler M . WT1 (Wilms' tumor suppressor gene). Atlas Genet Cytogenet Oncol Haematol. October 1999 .
URL : http://AtlasGeneticsOncology.org/Genes/WT1ID78.html

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Thu Nov 27 13:31:23 2008


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.